In the latest episode of “The Readout LOUD,” advisers react to the first psychedelic therapy presented to the FDA, as well as discussing the American Society of Clinical Oncology meeting. STAT colleague Meghana Keshavan helps dissect Lykos Therapeutics’ meeting with the FDA advisory committee. The episode also covers news in the health and life sciences, including updates from major biotech conferences. Topics include Lykos’ advisory committee meeting, the turmoil at BIO, a recap of ASCO, and Novartis’ acquisition of MorphoSys. Listeners can sign up for Adam’s newsletter, Biotech Scorecard, and subscribe to “The Readout LOUD” on various podcast platforms.
Source link
Psychedelics at the FDA, ASCO 2024 recap
